Anyone familiar with stock market screeners will know that shares in Biomed Lublin Wytwornia Surowic I Szczepionek Sa (WAR:BML) have been in an uptrend in recent months, with strong relative price strength on a 1-month, 6-month and 12-month basis.
Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders.
How has the Biomed Lublin Wytwornia Surowic I Szczepionek Sa (WAR:BML) share price performed?
In terms of relative price strength the stock has performed well against the market over the past year:
This is important because relative strength is a useful tool in the armoury of technical traders and investors. It’s an instant measure of how a stock has performed in comparison with a benchmark.
And while there are no certainties about which way a stock will move next, research shows that price trends like this often persist.
Studies by leading experts on momentum show that stocks with the strongest price strength tend to keep up the pace for anywhere up to one year, as investors increasingly buy into them.
Biomed Lublin Wytwornia Surowic I Szczepionek Sa is currently among the stocks with the strongest six-month and one-year relative price strength in the market. A look at its StockReport could offer more insight into what’s driving the momentum in its share price - and whether that might continue.
To find more stocks like Biomed Lublin Wytwornia Surowic I Szczepionek Sa, you'll need to equip yourself with professional-grade data and screening tools. This kind of information has traditionally been closely guarded by professional fund managers. But our team of financial analysts have carefully constructed this screen - Stockopedia’s Price Momentum - which gives you everything you need. So why not come and take a look?